XML 87 R67.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Collaborative and Licensing Arrangements - Amgen (Details) $ / shares in Units, $ in Thousands |  | 12 Months Ended
--- | --- | ---
Apr. 20, 2022 USD ($) $ / shares shares | Dec. 31, 2024 USD ($) | Dec. 31, 2019 USD ($) product
Ordinary Shares |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Share price, ADS (in dollars per share) | $ / shares | $ 132.74 |  |
Proceeds from ADS shares | $ 2,109,902 |  |
Amgen, Inc | Beigene Ltd |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Minority interest in investment (as a percent) | 20.50% |  |
Product Revenue | Product Concentration Risk | Amgen, Inc |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Concentration risk, percentage |  | 100.00% |
Amgen, Inc |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Number of products company has the right to retain | product |  |  | 1
Product retention period |  |  | 5 years
Maximum cash and development services commitment |  | $ 1,250,000 | $ 1,250,000
Shares issued (in shares) | shares | 15,895,001 |  |
Per share acquisition price (in dollars per share) | $ / shares | $ 174.85 |  |
Fair value of cost share liability | $ 601,857 |  |
Payments to acquire equity interest | 2,779,241 |  |
Fair value of equity investments issued | 2,162,407 |  |
Fair value of financing commitment | $ 616,834 |  |
Amgen, Inc | Minimum |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Commercialization term (years) |  |  | 5 years
Amgen, Inc | Maximum |  |  |
Research and Development Arrangement, Contract to Perform for Others |  |  |
Commercialization term (years) |  |  | 7 years
Royalties receiving period |  |  | 5 years

X
- Definition Collaborative Arrangements, Number Of Products Company Has The Right To Retain + References No definition available. + Details
Name: | bgne_CollaborativeArrangementsNumberOfProductsCompanyHasTheRightToRetain
Namespace Prefix: | bgne_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Collaborative Arrangements, Product Retention Period + References No definition available. + Details
Name: | bgne_CollaborativeArrangementsProductRetentionPeriod
Namespace Prefix: | bgne_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Commercialization Term + References No definition available. + Details
Name: | bgne_CommercializationTerm
Namespace Prefix: | bgne_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value of Equity Investments Issued + References No definition available. + Details
Name: | bgne_FairValueOfEquityInvestmentsIssued
Namespace Prefix: | bgne_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair Value Of Financing Commitment + References No definition available. + Details
Name: | bgne_FairValueOfFinancingCommitment
Namespace Prefix: | bgne_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair Value Of Liability Acquired + References No definition available. + Details
Name: | bgne_FairValueOfLiabilityAcquired
Namespace Prefix: | bgne_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum Cash And Services Development Commitment + References No definition available. + Details
Name: | bgne_MaximumCashAndServicesDevelopmentCommitment
Namespace Prefix: | bgne_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Proceeds From Issuance Of Asset Depository Shares + References No definition available. + Details
Name: | bgne_ProceedsFromIssuanceOfAssetDepositoryShares
Namespace Prefix: | bgne_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalties Receiving Period + References No definition available. + Details
Name: | bgne_RoyaltiesReceivingPeriod
Namespace Prefix: | bgne_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of each American Depository Share. Each American Depositary Share represents 13 ordinary shares of the entity. + References No definition available. + Details
Name: | bgne_SharePriceAmericanDepositoryShares
Namespace Prefix: | bgne_
Data Type: | dtr-types1:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 730 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1 + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=bgne_AmgenIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=bgne_BeigeneLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=bgne_AmgenIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |